1 / 8

R&I: Bacterial (Pyogenic) Meningitis Market Review

GlobalData's clinical trial report, “Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial (Pyogenic) Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial (Pyogenic) Meningitis. Detailed report at: http://www.reportsandintelligence.com/bacterial-pyogenic-meningitis-global-clinical-trials-review-h2-2014-market

ClaraBeaster111
Download Presentation

R&I: Bacterial (Pyogenic) Meningitis Market Review

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014 Publisher: Global Data No of pages: 100 Publish Date: Nov2014

  2. Description GlobalData'sclinical trial report, “Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial (Pyogenic) Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial (Pyogenic) Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bacterial (Pyogenic) Meningitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Enquire about report at: http://www.reportsandintelligence.com/enquire-about-report/153544

  3. Scope • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type • Listings of discontinued trials (suspended, withdrawn and terminated) • Get all reports of Pharmaceuticalscategory at: http://www.reportsandintelligence.com/pharmaceuticals-market-report

  4. Reasons to buy • Understand the dynamics of a particular indication in a condensed manner • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more • Obtain discontinued trial listing for trials across the globe • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies • View detailed report at: http://www.reportsandintelligence.com/bacterial-pyogenic-meningitis-global-clinical-trials-review-h2-2014-market

  5. Table Of Content Table of ContentsTable of Contents 2List of Tables 4List of Figures 5Introduction 6Bacterial (Pyogenic) Meningitis 6Report Guidance 6Clinical Trials by Region 7Clinical Trials and Average Enrollment by Country 8Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10Top Five Countries Contributing to Clinical Trials in Europe 11Top Countries Contributing to Clinical Trials in North America 12Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13Top Five Countries Contributing to Clinical Trials in Central and South America 14Clinical Trials by G7 Countries: Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials 15

  6. Table Of Content Clinical Trials by Phase in G7 Countries 16Clinical Trials in G7 Countries by Trial Status 17Clinical Trials by E7 Countries: Proportion of Bacterial (Pyogenic) Meningitis to Infectious Disease Clinical Trials 18Clinical Trials by Phase in E7 Countries 19Clinical Trials in E7 Countries by Trial Status 20Clinical Trials by Phase 21In Progress Trials by Phase 22Clinical Trials by Trial Status 23Clinical Trials by End Point Status 24Unaccomplished Trials of Bacterial (Pyogenic) Meningitis 25Subjects Recruited Over a Period of Time 27Clinical Trials by Sponsor Type 28Prominent Sponsors 29Top Companies Participating in Bacterial (Pyogenic) Meningitis Therapeutics Clinical Trials 30 Prominent Drugs 32

  7. Table Of Content Clinical Trial Profiles 33Clinical Trial Overview of Top Companies 33Novartis AG 33Clinical Trial Overview of Novartis AG 33Pfizer Inc. 37Clinical Trial Overview of Pfizer Inc. 37GlaxoSmithKline plc 40Clinical Trial Overview of GlaxoSmithKline plc 40Sanofi 42Clinical Trial Overview of Sanofi 42Serum Institute of India Limited 43Clinical Trial Overview of Serum Institute of India Limited 43Baxter International Inc. 44 Get full TOC at: http://www.reportsandintelligence.com/bacterial-pyogenic-meningitis-global-clinical-trials-review-h2-2014-market/table-of-contents

  8. FOR MORE DETAILS Visit us at : http://www.reportsandintelligence.com/bacterial-pyogenic-meningitis-global-clinical-trials-review-h2-2014-market Stay With Us: • TELEPHONE: Direct: +1 (617) 674-4143 • Toll Free: +1 (855) 711-1555E-MAIL: sales@reportsandintelligence.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States

More Related